Advanced/metastatic malignant solid tumors

Clinical trials for Advanced/metastatic malignant solid tumors explained in plain language.

Never miss a new study

Get alerted when new Advanced/metastatic malignant solid tumors trials appear

Sign up with your email to follow new studies for Advanced/metastatic malignant solid tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo targets Hard-to-Treat cancers in early trial

Disease control By invitation only

This early-stage trial tests a new drug called HLX43, an antibody-drug conjugate that targets PD-L1, in people with advanced or metastatic solid tumors that have not responded to standard treatments. Participants also receive another immunotherapy drug, serplulimab (HLX10). The m…

Matched conditions: ADVANCED/METASTATIC MALIGNANT SOLID TUMORS

Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

Advanced/metastatic malignant solid tumors

Get alerted when new Advanced/metastatic malignant solid tumors trials appear

New drug combo targets Hard-to-Treat cancers in early trial